Bayer HealthCare AG Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	44
ISBN Number	not applicable
Product Code	GMD04780

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Bayer HealthCare AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook In Vitro Diagnostics
3 Business Description
- 3.1 Business Overview
- 3.2 Animal Health
  - 3.2.1 Overview
  - 3.2.2 Financials
  - 3.2.3 Key Strategies
- 3.3 Consumer Care
  - 3.3.1 Overview
  - 3.3.2 Financials
  - 3.3.3 Key Strategies
- 3.4 Diabetes Care
  - 3.4.1 Overview
  - 3.4.2 Financials
  - 3.4.3 Key Strategies
- 3.5 Pharmaceuticals
  - 3.5.1 Overview
  - 3.5.2 Financials
  - 3.5.3 Market View
  - 3.5.4 Key Strategies
- 3.6 Major Products and Services
  - 3.6.1 Overview
4 History
5 Business Strategy
- 5.1 Mission Statement
- 5.2 Strategy
- 5.3 Corporate Social Responsibility
  - 5.3.1 Overview
  - 5.3.2 Specific CSR Initiatives
6 Value Chain Analysis
- 6.1 Manufacturing
  - 6.1.1 In House Manufacturing
  - 6.1.2 Outsourcing
- 6.2 Product Development
  - 6.2.1 Regulatory Approvals
  - 6.2.2 Clinical Trials
  - 6.2.3 Research and Development
- 6.3 Sales and Marketing
  - 6.3.1 Partnerships and Alliances
  - 6.3.2 Licensing Agreements
7 Competitors
8 Key Employees
9 Key Employee Biographies
10 Company Statement
11 Locations And Subsidiaries
- 11.1 Head Office
- 11.2 Other Locations & Subsidiaries
12 Recent Developments
- 12.1 Financial Announcements
  - 12.1.1 Nov 06, 2007: Bayer Declares Q3 2007 Results
  - 12.1.2 Aug 07, 2007: Bayer Declares Q2 2007 Results
  - 12.1.3 Apr 26, 2007: Bayer Declares Q1 2007 Results
  - 12.1.4 Mar 15, 2007: Bayer Declares 2006 Results
- 12.2 Corporate Communications
  - 12.2.1 Sep 05, 2007: Bayer Intends To Delist From NYSE
- 12.3 Product News
  - 12.3.1 Mar 11, 2008: Bayer HealthCare Pharmaceuticals Introduces VistaTrak An Innovative Contrast Media Management System
  - 12.3.2 Dec 01, 2007: Bayer Opens New Door To Contrast Media Safety
  - 12.3.3 Dec 01, 2007: Bayer Opens Pilot Plant For Bioresorbable Wound Dressings(Wound treatment)
- 12.4 Clinical Trials
  - 12.4.1 Dec 01, 2007: Bayer Opens Pilot Plant For Bioresorbable Wound Dressings(Wound treatment)
13 Bayer HealthCare AG Pipeline Products
- 13.1 Bayer HealthCare AG Product Pipeline Analysis
  - 13.1.1 Bayer HealthCare AG Pipeline Products By Equipment Type
  - 13.1.2 Bayer HealthCare AG Pipeline Products By Development Stage
  - 13.1.3 Bayer HealthCare AG Pipeline Products By Therapy Area
  - 13.1.4 Bayer HealthCare AG Pipeline Products By News Summary
- 13.2 Bioresorbable wound dressings
  - 13.2.1 Product Description
  - 13.2.2 Product Status
  - 13.2.3 Product Milestone
- 13.3 Anti-inflammatory drug coated Silica gel fiber
  - 13.3.1 Product Description
  - 13.3.2 Product Status
- 13.4 Analgesic Coated Silica Gel fiber
  - 13.4.1 Product Description
  - 13.4.2 Product Status
- 13.5 Blood glucose monitor
  - 13.5.1 Product Description
  - 13.5.2 Product Status
  - 13.5.3 Pricing
  - 13.5.4 Product Milestone
- 13.6 VistaTrak
  - 13.6.1 Product Description
  - 13.6.2 Product Status
  - 13.6.3 Product Milestone
14 Appendix
- 14.1 Methodology
  - 14.1.1 Coverage
  - 14.1.2 Secondary Research
  - 14.1.3 Primary Research
  - 14.1.4 Expert Panel Validation
- 14.2 Contact Us
- 14.3 About Global Markets Direct
- 14.4 Disclaimer
1 List of Tables
- Table 1: Bayer HealthCare AG,Key Facts, 2006
- Table 2: Bayer HealthCare AG, Key Employees, 2006
- Table 3: Bayer HealthCare AG, Other Locations
- Table 4: Bayer HealthCare AG Pipeline Products by Equipment Type
- Table 5: Bayer HealthCare AG Pipeline Products By Development Stage
- Table 6: Bayer HealthCare AG Pipeline Products By Therapy Area
- Table 7: Bayer HealthCare AG Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: Bayer HealthCare AG, Value Chain Analysis
- Figure 2: Bayer HealthCare AG Pipeline Products By Equipment Type
- Figure 3: Bayer HealthCare AG Pipeline Products By Equipment Type
- Figure 4: Bayer HealthCare AG Pipeline Products By Development Stage
- Figure 5: Bayer HealthCare AG Pipeline Products By News Summary
- Figure 6: Global Markets Direct Methodology